Research Use Only (RUO) assay now available
for BD MAX™ System users
FRANKLIN
LAKES, N.J., July 27,
2022 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company,
and CerTest Biotec today announced their newly developed molecular
polymerase chain reaction (PCR) test for the monkeypox virus is now
commercially available outside of the
United States for use in research applications by
laboratories.
The assay leveraged the BD MAX™ System open system reagent suite
to develop the CerTest VIASURE Monkeypox molecular test on the BD
MAX™ System.
"One of the key advantages of the BD MAX™ System is its
open-architecture system that enables rapid response to emerging
health threats," said Nikos
Pavlidis, vice president of Molecular Diagnostics at BD.
"Just as we did at the beginning of the COVID-19 pandemic, we
partnered with CerTest to quickly develop a molecular test to help
better understand and track this disease."
The BD MAX™ System is a fully integrated, automated platform
that performs nucleic acid extraction and real-time PCR providing
results for up to 24 samples across multiple syndromes in less than
three hours. BD offers an extensive menu of tests on the system
covering health care associated infections, respiratory infections,
sexually transmitted infections, gastrointestinal infections and
women's health. BD offers a suite of open system reagents for the
BD MAX™ System that enables labs to fully automate and streamline
their Lab Developed Tests.
"Speed is of the essence when responding to what the World
Health Organization has declared a global health emergency,"
Nelson Fernandes, managing director
of CerTest Biotec. "We hope this new test will boost capacity for
monkeypox research, ultimately helping quell the spread of the
disease."
As with all CerTest tests, the Monkeypox PCR Detection Kit for
the BD MAX™ System is offered in a lyophilized format. Accordingly,
the test will come in a tube that snaps into the test-specific
position on the BD MAX™ ExK™ TNA extraction strip, which is
supplied by BD.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 75,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/ and Twitter @BDandCo.
About CerTest
CerTest Biotec is a European company established in 2002 for the
development and manufacturing of in vitro diagnostic medical
devices. Today, CerTest is a global company structured around seven
business units offering one of the widest portfolios for human In
Vitro Diagnostic and Pharma. The company bases its future on a
strong technical knowledge and expertise in the detection of human
diseases. CerTest last generation laboratories, state-of-the-art
technical equipment and skilled professionals are the keys for
providing reliable solutions for the medical diagnostic
professional.
Contacts:
|
|
|
|
Media:
|
Investors:
|
Troy Kirkpatrick
|
Francesca
DeMartino
|
VP, Public
Relations
|
SVP, Head of Investor
Relations
|
858.617.2361
|
201.847.5743
|
troy.kirkpatrick@bd.com
|
francesca.demartino@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-certest-biotec-announce-commercial-launch-of-monkeypox-test-301594063.html
SOURCE BD (Becton, Dickinson and Company)